Synthesis and biological evaluation of new naphthoquinone-containing pyrrolo-thiazoles as anticancer agents
摘要:
Abstractmagnified image
Naphthoquinones undergo 1,3‐dipolar cycloaddition with bicyclic münchnones generated from thiazolidines affording new pyrrolo‐thiazoles with a fused quinone nucleus. The products were obtained as single enantiomers in good yields. These benzo[f]thiazolo[4,3‐a]isoindole‐6,11(1H,3H)‐diones are comprised of four fused rings and present a very planar structure. The evaluation of their anticancer activity against melanoma A375 and colorectal adenocarcinoma WiDr human cell lines showed only moderate activity but gave insight into the modeling of new structures. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.] J. Heterocyclic Chem., (2010).
The preparation of thiazolidine-4-carboxylicacidderivativescontaining a 2-nitrooxyethylamine group, potentially active as vasodilators, is reported. Their 1H nmrstudies carried out to establish the configuration of the C2 stereocenter and the full assignment of their 1H and 13C nmr spectra, are also reported.
据报道,含有2-硝基氧乙胺基的噻唑烷-4-羧酸衍生物的制备具有潜在的血管扩张作用。他们还进行了1 H nmr研究,以建立C2立体中心的构型,并完整报道了其1 H和13 C nmr光谱。
The present invention provides κ opioid receptor agonists comprising 2-phenylbenzothiazoline derivatives. The present invention relates to κ opioid receptor agonists comprising compounds or salts thereof having the chemical structure represented by the general formula [I]. Namely, it is important for exhibition of the κ opioid receptor agonist actions to have an alkyl group having an amino group at a phenyl group of 2-phenylbenzothiazoline as a substituent and to have an acyl group at a nitrogen atom of 2-phenylbenzothiazoline,
wherein R is alkyl having the amino group as the substituent; and R
1
is acyl.
Method for treating pain or pruritis by administering opinoid receptor agonist comprising 2-phenylbenzothiazoling derivative
申请人:Tokai Maki
公开号:US20060205796A1
公开(公告)日:2006-09-14
A method of treating pain or pruritis comprising administering to a patient in need thereof a pharmaceutically effective amount of a κ opioid receptor agonist of the formula
wherein R is an alkyl having an amino group as a substituent; and R
1
is acyl.
The present invention provides κ opioid receptor agonists comprising 2-phenylbenzothiazoline derivatives. The present invention relates to κ opioid receptor agonists comprising compounds or salts thereof having the chemical structure represented by the general formula [I]. Namely, it is important for exhibition of the κ opioid receptor agonist actions to have an alkyl group having an amino group at a phenyl group of 2-phenylbenzothiazoline as a substituent and to have an acyl group at a nitrogen atom of 2-phenylbenzothiazoline,
wherein R is alkyl having the amino group as the substituent; and R1 is acyl.
本发明提供了由 2-苯基苯并噻唑啉衍生物组成的 κ 阿片受体激动剂。本发明涉及由具有通式[I]所代表的化学结构的化合物或其盐组成的κ阿片受体激动剂。也就是说,对于展示κ阿片受体激动剂的作用而言,重要的是在 2-苯基苯并噻唑啉的苯基上具有氨基的烷基作为取代基,并且在 2-苯基苯并噻唑啉的氮原子上具有酰基、
其中 R 是以氨基为取代基的烷基;R1 是酰基。
Heterocyclische Verbindungen aus Zuckern, XV: Zur Konfiguration chiraler C-2-substituierter 4-Thiazolidincarbons�uren. Chiralit�tstransfer auf C-3 in 3,4-Dihydro-1H-pyrrolo[1,2-c]thiazolen
5-Substituted 3,4-dihydro-pyrrolo[1,2-c]thiazole-6,7-dicarboxylic acid esters 3 are obtained from 2-substituted-3-acyl-1,3-thiazolidine-4-carboxylic acids, 1 in [3 + 2]-cycloaddition reactions via mesoionic oxazolone (''munchnone'') intermediates. The chirality at C-4 of the starting carboxylic acids 1 is eliminated in the products 3, and the chirality at C-3 (C-2 in the starting carboxylic acids 1) can thus be determined through chiroptical measurements. Several representatives of the ring system 3 have been characterised through H-1- and CD-spectra and the molecular structure of (3S)-3da has been determined by X-ray crystallography.